Provided by Tiger Trade Technology Pte. Ltd.

Meiragtx Holdings Plc

14.34
-0.2000-1.38%
Post-market: 14.340.00000.00%19:30 EDT
Volume:635.48K
Turnover:9.12M
Market Cap:1.38B
PE:15.28
High:14.85
Open:14.70
Low:14.10
Close:14.54
52wk High:15.35
52wk Low:6.62
Shares:96.04M
Float Shares:53.68M
Volume Ratio:0.73
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9383
EPS(LYR):-1.4199
ROE:72.17%
ROA:38.65%
PB:6.39
PE(LYR):-10.10

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Decibel Cannabis Company (OtherDBCCF), Abbott Laboratories (ABT) and Meiragtx Holdings (MGTX)

TIPRANKS
·
Apr 17

RBC Raises Price Target on MeiraGTx Holdings to $24 From $16, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Apr 17

MeiraGTx Holdings Down Over 19%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk

Dow Jones
·
Apr 16

Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson

Benzinga_recent_news
·
Apr 16

MeiraGTx prices 11,111,111-share offering at $9 for USD 100 million

Reuters
·
Apr 16

MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares

THOMSON REUTERS
·
Apr 16

MeiraGTx Holdings Plc - Pricing of Offering at Price of $9.00 per Share

THOMSON REUTERS
·
Apr 16

MeiraGTx Holdings Plc - to Pay Janssen Mid-Teens Percentage Royalties on Global Rpgr Sales From July 1, 2029 - SEC Filing

THOMSON REUTERS
·
Apr 16

MeiraGTx Holdings Plc - Xlrp Deal Includes $50 Mln Contingent Payment by Janssen for Rpgr Product Based on Milestones Being Achieved - SEC Filing

THOMSON REUTERS
·
Apr 16

MeiraGTx Holdings Plc - Jjdc and Janssen Agree to 12-Month Lock-up on MeiraGTx Shares After Closing - SEC Filing

THOMSON REUTERS
·
Apr 16

MeiraGTx buys XLRP gene therapy bota-vec from J&J for $25 million upfront

Reuters
·
Apr 16

MeiraGTx Holdings Plc - to Immediately Pursue Global Regulatory Filings for Bota-Vec Approval

THOMSON REUTERS
·
Apr 16

MeiraGTx Holdings Plc - to Pay $25 Mln Upfront, Milestone, and High Double-Digit Royalty to J&J for Bota-Vec

THOMSON REUTERS
·
Apr 16

MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (Bota-Vec) for the Treatment of X-Linked Retinitis Pigmentosa (Xlrp)

THOMSON REUTERS
·
Apr 16

MeiraGTx reports positive three-year Phase 1 data for AAV-hAQP1 in xerostomia

Reuters
·
Apr 16

MeiraGTx Announces Positive Three-Year Data From the Phase 1 Aquax Clinical Study of Aav-Haqp1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia

THOMSON REUTERS
·
Apr 16

MeiraGTx Holdings Plc - Clinically Meaningful Improvements in Xerostomia Symptoms Maintained for 3 Years Post Treatment

THOMSON REUTERS
·
Apr 16

MeiraGTx Holdings Plc - Aav-Haqp1 Safe and Well Tolerated at All Doses Tested

THOMSON REUTERS
·
Apr 16

MeiraGTx to present 3-year Phase 1 AQUAx data for AAV-hAQP1 in xerostomia

Reuters
·
Apr 14

MeiraGTx Chief Dev. Officer Stuart Naylor sells USD 258,507 shares

Reuters
·
Apr 08